FT500 Gene Therapeutics needed more than just a new ERP system—They were looking for a finance foundation that could scale globally and support real-time decision-making. Their goal was to replace fragmented tools with a modern, integrated solution that ensures compliance, boosts efficiency, and drives long-term value. Let’s look into how Quantisage helped dive deep into the ERP Vendor assessment process with the client and helped client choose the right system to support its long-term vision.
Client: New England based Gene Therapeutics
Industry: Life Sciences
Size: 3000+ employees
Location: Boston
A diversified enterprise operating in 6 jurisdictions was struggling with five disjointed legacy finance applications that:
The leadership team needed an accelerated, data-driven vendor-selection process that would compare best-fit ERP integration suites and prove long-term scalability.
“We set out to replace guesswork with data-driven clarity—and in eight weeks we had a vendor decision we could trust. The new platform hasn’t just unified our finance stack; it’s freed our team to focus on growth instead of spreadsheets.”
— Chief Financial Officer
We have the experience, knowledge, and flexibility to help you with business transformation, hybrid workplace strategy, technology implementation and adoption, and more.